BVL
BIIB icon

Beau Ventures, LLc’s Biogen BIIB Stock Holding History

Beau Ventures, LLc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.6M Hold
100,000
– – 2.13% 8
2026
Q2 		$21.6M Hold
100,000
– – 2.35% 8
2026
Q1 		$18.3M Hold
100,000
– – 2.46% 7
2025
Q4 		$17.6M Buy
+100,000
New +$16.3M 2.19% 7

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Beau Ventures, LLc's BIIB Position: Q3 2026 in Review

Beau Ventures, LLc held its Biogen (BIIB) position steady in Q3 2026 at 100,000 shares worth $22.6M. The position accounts for 2.13% of the portfolio, ranked #8.

Beau Ventures, LLc first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Beau Ventures, LLc held 100,000 shares of Biogen worth $22.6M as of Q3 2026.
  • Beau Ventures, LLc left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 2.13% of Beau Ventures, LLc's portfolio in Q3 2026, its #8 holding.
  • Beau Ventures, LLc first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 76 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Beau Ventures, LLc's 13F filing for Q3 2026, filed 14 Oct 2026.